Press Releases July 23, 2026 10:00 AM

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast

Indivior Announces Date for Second Quarter 2026 Financial Results and Webcast Presentation

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
INDV

Indivior Pharmaceuticals, a leader in opioid use disorder treatments, will release its Q2 2026 financial results on August 4, 2026, followed by a webcast with the CEO and leadership team. The company focuses on long-acting injectable therapies for opioid addiction and emphasizes its commitment to advancing addiction medicine.

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
INDV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Scheduled Q2 2026 financial results release and webcast presentation on August 4, 2026.
  • Indivior leads in long-acting injectable treatments for opioid use disorder, highlighting its focus on addiction medicine.
  • The webcast and related materials will be accessible via the company’s website and allow investors to engage with leadership.
  • The healthcare and pharmaceuticals sectors, specifically addiction treatment and biotech markets, are impacted by Indivior's financial performance and updates.

RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.

Access to the Live Webcast Presentation:

The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins.

Live webcast link: https://edge.media-server.com/mmc/p/yoi9z435

Participants may access the presentation telephonically by registering with the following link:

https://register-conf.media-server.com/register/BI13430f5332af466c963ac5c255f202e0

(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)

A replay of the presentation will be available at www.indivior.com.

About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine, developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities – we are powering recovery and renewing hope. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior. 

For Further Information

Investors:
Jason Thompson
Indivior
Tel: 804-402-7123
E-mail: [email protected]

Media:
Cassie France-Kelly
Indivior
Tel: 804-594-0836
E-Mail: [email protected]


Risks

  • Financial results may not meet market expectations, impacting investor sentiment in healthcare stocks.
  • Regulatory changes or competition in addiction treatment therapies could affect company growth.
  • Execution risks related to advancing new treatments and maintaining market leadership in opioid use disorder therapies.

More from Press Releases

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships Jul 23, 2026 GBank Financial Holdings Inc. is Pleased To Share the Press Release of Bankroll LLC [BVNKROLL] Jul 23, 2026 EZCORP to Release Third Quarter Fiscal 2026 Results After Market Close on Wednesday, August 5, 2026 Jul 23, 2026 Silvercrest Asset Management Rebrands International and Global Value Platform as the Silvercrest Focused Value Platform Jul 23, 2026 CBIZ Launches CBIZ Retirement Advantage PEP (Pooled Employer Plan) to Help Middle-Market Businesses Attract, Retain and Reward Talent by Simplifying Retirement Plan Administration and Enhancing Employee Benefits Jul 23, 2026